191 related articles for article (PubMed ID: 7507056)
1. Intrathecal 5-methoxy-N,N-dimethyltryptamine in mice modulates 5-HT1 and 5-HT3 receptors.
Alhaider AA; Hamon M; Wilcox GL
Eur J Pharmacol; 1993 Nov; 249(2):151-60. PubMed ID: 7507056
[TBL] [Abstract][Full Text] [Related]
2. The paradox of 5-methoxy-N,N-dimethyltryptamine: an indoleamine hallucinogen that induces stimulus control via 5-HT1A receptors.
Winter JC; Filipink RA; Timineri D; Helsley SE; Rabin RA
Pharmacol Biochem Behav; 2000 Jan; 65(1):75-82. PubMed ID: 10638639
[TBL] [Abstract][Full Text] [Related]
3. Pharmacodynamic effects of serotonin (5-HT) receptor ligands in pigs: stimulation of 5-HT2 receptors induces malignant hyperthermia.
Löscher W; Witte U; Fredow G; Ganter M; Bickhardt K
Naunyn Schmiedebergs Arch Pharmacol; 1990 Jun; 341(6):483-93. PubMed ID: 2118235
[TBL] [Abstract][Full Text] [Related]
4. Involvement of 5-HT2 receptors in the behaviours produced by intrathecal administration of selected 5-HT agonists and the TRH analogue (CG 3509) to rats.
Fone KC; Johnson JV; Bennett GW; Marsden CA
Br J Pharmacol; 1989 Mar; 96(3):599-608. PubMed ID: 2470455
[TBL] [Abstract][Full Text] [Related]
5. A behavioural and biochemical study in mice and rats of putative selective agonists and antagonists for 5-HT1 and 5-HT2 receptors.
Goodwin GM; Green AR
Br J Pharmacol; 1985 Mar; 84(3):743-53. PubMed ID: 2580582
[TBL] [Abstract][Full Text] [Related]
6. Differential roles of 5-hydroxytryptamine1A and 5-hydroxytryptamine1B receptor subtypes in modulating spinal nociceptive transmission in mice.
Alhaider AA; Wilcox GL
J Pharmacol Exp Ther; 1993 Apr; 265(1):378-85. PubMed ID: 7682614
[TBL] [Abstract][Full Text] [Related]
7. The serotonergic hallucinogen 5-methoxy-N,N-dimethyltryptamine disrupts cortical activity in a regionally-selective manner via 5-HT(1A) and 5-HT(2A) receptors.
Riga MS; Bortolozzi A; Campa L; Artigas F; Celada P
Neuropharmacology; 2016 Feb; 101():370-8. PubMed ID: 26477571
[TBL] [Abstract][Full Text] [Related]
8. Potentiation of 5-methoxy-N,N-dimethyltryptamine-induced hyperthermia by harmaline and the involvement of activation of 5-HT1A and 5-HT2A receptors.
Jiang XL; Shen HW; Yu AM
Neuropharmacology; 2015 Feb; 89():342-51. PubMed ID: 25446678
[TBL] [Abstract][Full Text] [Related]
9. Intracerebroventricular morphine produces antinociception by evoking gamma-aminobutyric acid release through activation of 5-hydroxytryptamine 3 receptors in the spinal cord.
Kawamata T; Omote K; Toriyabe M; Kawamata M; Namiki A
Anesthesiology; 2002 May; 96(5):1175-82. PubMed ID: 11981159
[TBL] [Abstract][Full Text] [Related]
10. The roles of 5-HT1A and 5-HT2 receptors in the effects of 5-MeO-DMT on locomotor activity and prepulse inhibition in rats.
Krebs-Thomson K; Ruiz EM; Masten V; Buell M; Geyer MA
Psychopharmacology (Berl); 2006 Dec; 189(3):319-29. PubMed ID: 17013638
[TBL] [Abstract][Full Text] [Related]
11. Modification of the effects of 5-methoxy-N,N-dimethyltryptamine on exploratory behavior in rats by monoamine oxidase inhibitors.
Halberstadt AL; Buell MR; Masten VL; Risbrough VB; Geyer MA
Psychopharmacology (Berl); 2008 Nov; 201(1):55-66. PubMed ID: 18604652
[TBL] [Abstract][Full Text] [Related]
12. 5-hydroxytryptamine3 (5-HT3) receptors mediate spinal 5-HT antinociception: an antisense approach.
Paul D; Yao D; Zhu P; Minor LD; Garcia MM
J Pharmacol Exp Ther; 2001 Aug; 298(2):674-8. PubMed ID: 11454930
[TBL] [Abstract][Full Text] [Related]
13. Modification of 5-methoxy-N,N-dimethyltryptamine-induced hyperactivity by monoamine oxidase A inhibitor harmaline in mice and the underlying serotonergic mechanisms.
Jiang XL; Shen HW; Yu AM
Pharmacol Rep; 2016 Jun; 68(3):608-15. PubMed ID: 26977821
[TBL] [Abstract][Full Text] [Related]
14. Repeated administration of low doses of cocaine enhances the sensitivity of 5-HT2 receptor function.
Darmani NA; Martin BR; Glennon RA
Pharmacol Biochem Behav; 1992 Mar; 41(3):519-27. PubMed ID: 1584831
[TBL] [Abstract][Full Text] [Related]
15. Behavioral and pharmacokinetic interactions between monoamine oxidase inhibitors and the hallucinogen 5-methoxy-N,N-dimethyltryptamine.
Halberstadt AL
Pharmacol Biochem Behav; 2016 Apr; 143():1-10. PubMed ID: 26780349
[TBL] [Abstract][Full Text] [Related]
16. Characterization of the role of spinal N-methyl-D-aspartate receptors in thermal nociception in the rat.
Kolhekar R; Meller ST; Gebhart GF
Neuroscience; 1993 Nov; 57(2):385-95. PubMed ID: 7906873
[TBL] [Abstract][Full Text] [Related]
17. Blockade and reversal of 5-methoxy-N,N-dimethyltryptamine-induced analgesia following noradrenaline depletion.
Archer T; Minor BG; Post C
Brain Res; 1985 Apr; 333(1):55-61. PubMed ID: 3158373
[TBL] [Abstract][Full Text] [Related]
18. Different role of 5-HT1A and 5-HT2 receptors in spinal cord in the control of nociceptive responsiveness.
Eide PK; Hole K
Neuropharmacology; 1991 Jul; 30(7):727-31. PubMed ID: 1717872
[TBL] [Abstract][Full Text] [Related]
19. Effects of 5-HT2 and 5-HT3 receptors on the modulation of nociceptive transmission in rat spinal cord according to the formalin test.
Sasaki M; Ishizaki K; Obata H; Goto F
Eur J Pharmacol; 2001 Jul; 424(1):45-52. PubMed ID: 11470259
[TBL] [Abstract][Full Text] [Related]
20. Spinal 5-HT3 receptor-mediated antinociception: possible release of GABA.
Alhaider AA; Lei SZ; Wilcox GL
J Neurosci; 1991 Jul; 11(7):1881-8. PubMed ID: 2066767
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
